Table 1 Baseline patient demographics

Gender

Male

138 (53.3%)

27 (56.3%)

Female

121 (46.7%)

21 (43.8%)

Age in years

14 or under

1 (0.4%)

0 (0.0%)

15-64

60 (23.2%)

13 (27.1%)

65 or over

198 (76.4%)

35 (32.9%)

Suspected source of infection

Respiratory tract

85 (32.8%)

11 (22.9%)

Digestive tract

78 (30.1%)

25 (52.1%)

<0.05

Urinary tract

19 (7.3%)

2 (4.2%)

Biliary tract

28 (10.8%)

4 (8.3%)

Others

26 (10.0%)

6 (12.5%)

Unknown

35 (13.5%)

2 (4.2%)

Surgery

84 (34.0%)

27 (56.3%)

<0.05

Baseline AT activity

<30%

88 (34.0%)

19 (39.6%)

30%

171 (66.0%)

29 (60.4%)

SD

31.02 ± 7.25

29.57 ± 8.22

Baseline DIC score

4.5

143 (55.2%)

26 (54.2%)

6

48 (18.5%)

10 (20.8%)

7.8

68 (26.3%)

12 (25.0%)

SD

5.6 ± 1.3

5.7 ± 1.4

Baseline SOFA score

0-6

27 (26.5%)

5 (31.3%)

7-12

46 (45.1%)

9 (56.3%)

13-24

29 (28.4%)

2 (12.5%)

SD

10.1 ± 4.7

7.7 ± 4.3

Median baseline platelet count, × 10⁴/mm³

6.0 (IQR 3.15-9.1)

7.9 (IQR 5.0-11.4)

<0.05

Median baseline FDP, μg/mL

22.1 (IQR 11.5-37.8)

23.7 (IQR 5.0-11.4)

<0.05

Heparin

64 (24.7%)

8 (16.7%)

Thrombomodulin

15 (5.8%)

3 (6.3%)